CMO
Boehringer says it is rolling out ‘fully disposable’ biomanufacturing
September 18, 2012Manufacturing and Production Boehringer, CMO, GMP, SUSs
Boehringer Ingelheim says it has developed a production platform for biopharmaceuticals that makes full use disposable technologies both upstream and …
Boehringer wins contract to make Servier’s gevokizumab
August 7, 2012Manufacturing and Production Boehringer Ingelheim, CMO, Servier, antibody
Boehringer Ingelheim’s contract manufacturing organisation (CMO) division will provide commercial-scale manufacturing of a new monoclonal antibody developed by Servier and …
Scinopharm Taiwan to build injectable drug facility
July 3, 2012Manufacturing and Production CMO, HPAPI, R&D, Scinopharm Taiwan
Contract manufacturing organisation Scinopharm Taiwan has said it plans to invest around $37.6 million in a new high-potency active pharmaceutical …
Europe’s CMO market set to double by 2018, says F&S
May 30, 2012Manufacturing and Production CMO, Europe, F&S, R&D, Taylor, manufacturing
The European market for pharmaceutical contract manufacturing will double from a value of around $10 billion last year to almost …
Onyx appoints Brian Jolly to commercial team
May 30, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing CMO, Onyx, manufacturing
Onyx Scientific the chemistry and manufacturing specialist has bolstered its business development team with the appointment of a new director. …
AMRI announces president for AMRI Europe
May 23, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AMRI, AMRI Europe, CMO
Contract research and manufacturing organisation AMRI has announced the appointment of Ian Shott as president of AMRI Europe. In this …
Outsourcing on the up, but contract manufacturing still under pressure
May 11, 2012Manufacturing and Production CMO, Jim Millar, PharmaSource, Phil Taylor, outsourcing
The pharmaceutical contract services sector experienced something for a recovery in 2011 after a lean couple of years, although the …
Patheon starts winding down Swindon operations
May 10, 2012Manufacturing and Production CMO, Patheon, Swindon, manufacturing
North American contract manufacturer Patheon is winding down some operations at its facility in Swindon, UK, with the aim of …
Teva sells Canadian plant to CMO
March 30, 2012Manufacturing and Production CMO, Halo Pharmaceutical, Teva, manufacturing
Teva has said it plans to sell a manufacturing facility in Quebec, Canada, to US contract manufacturing organisation Halo Pharmaceutical. …
Lonza profits slide as exchange rates bite
August 9, 2011Manufacturing and Production CMO, Lonza
A strong Swiss franc has pegged back first-half profits at fine chemical and contract manufacturer Lonza, although the company said …
‘Largest biopharma CMO in Asia’ gets green light
March 25, 2010Manufacturing and Production Biomanufacturing, CMO, manufacturing
A US biotechnology company is spearheading a project to create what will be the largest biopharmaceutical contract manufacturing organisation in …
Cambrex sales rise in Q3 despite ‘challenging environment’
November 9, 2009Manufacturing and Production, Research and Development CMO, CRO
Contract development and manufacturing services firm Cambrex saw its sales advance 2% to $58 million in the third quarter on …
DSM looking for new Chinese ingredient partners
November 4, 2009Manufacturing and Production CMO, DSM
Dutch fine chemicals company DSM has said it will look for new partners in China after dissolving a joint venture …
Lonza cuts staff, issues profits warning
November 2, 2009Manufacturing and Production CMO
Swiss contract manufacturer and fine chemical firm Lonza has announced it will cut around 5% of its workforce and may …
Chinese contract manufacturers to benefit from downturn
February 2, 2009Manufacturing and Production CMO, China
China's contract manufacturing organisation market was valued at more than $70 billion in 2007, with pharmaceuticals comfortably the largest contributor, …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
